Goldman Sachs Upgrades Impax Laboratories (IPXL) to Neutral
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Goldman Sachs upgraded Impax Laboratories (NASDAQ: IPXL) from Sell to Neutral.
Shares of Impax Laboratories closed at $25.40 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Upgrades ICICI Bank (IBN) to Buy
- BMO Capital Upgrades Kinder Morgan (KMI) to Outperform
- Stephens Upgrades Chesapeake Energy (CHK) to Equal Weight
Create E-mail Alert Related CategoriesUpgrades
Related EntitiesGoldman Sachs
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!